Bailard’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,640
Closed -$260K 699
2023
Q1
$260K Hold
11,640
0.01% 554
2022
Q4
$309K Sell
11,640
-1,000
-8% -$32.6K 0.01% 503
2022
Q3
$359K Hold
12,640
0.01% 424
2022
Q2
$263K Buy
12,640
+2,716
+27% +$50.9K 0.01% 525
2022
Q1
$215K Sell
9,924
-9,300
-48% -$202K 0.01% 651
2021
Q4
$534K Sell
19,224
-600
-3% -$14.5K 0.02% 398
2021
Q3
$421K Hold
19,824
0.01% 434
2021
Q2
$327K Hold
19,824
0.01% 493
2021
Q1
$248K Sell
19,824
-2,462
-11% -$26.1K 0.01% 584
2020
Q4
$198K Buy
+22,286
New +$181K 0.01% 586

Other funds holding CCRN

Bailard's CCRN Position: Q2 2023 in Review

Bailard sold out of Cross Country Healthcare (CCRN) in Q2 2023, closing a stake of 11,640 shares — an estimated $260K sold.

Bailard first reported a position in CCRN in Q4 2020 and held it in 10 quarters. The position peaked at $534K in Q4 2021. 194 funds tracked by Wall St. Rank hold CCRN as of Q2 2023.

  • Bailard reported no remaining Cross Country Healthcare position as of Q2 2023 after selling out during the quarter.
  • Bailard sold 11,640 Cross Country Healthcare shares in Q2 2023, an estimated $260K.
  • Bailard first reported a position in Cross Country Healthcare in Q4 2020 and held it in 10 quarters.
  • Bailard's Cross Country Healthcare position peaked at $534K in Q4 2021.
  • 194 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2023.

Based on Bailard's 13F filing for Q2 2023, filed 20 Jul 2023.